The landscape of surgical intervention is continuously evolving, and Levita Magnetics is at the forefront of this transformation with its recent expansion of the MARS (magnetic-assisted robotic surgery) system. With expanded FDA 510(k) clearance, MARS and its Magnetic Surgical System (MSS) are now
In recent years, public health experts have increasingly highlighted an unexpected consequence of climate change: the significant rise in allergies worldwide. As global temperatures climb and pollutants proliferate, the frequency and severity of allergic reactions have become an urgent issue
In a substantial shift towards more inclusive health policy, Texas has taken significant strides to expand access to medical cannabis under House Bill 46. This legislation marks a notable transition for the state's medical cannabis framework, broadening both the scope of eligibility and the
The advent of Yeztugo, a twice-yearly injectable medication for HIV prevention, is sparking significant interest in the medical community. Approved by the U.S. Food and Drug Administration (FDA), this breakthrough drug offers a new option for adults and adolescents weighing at least 77 pounds,
Does innovation in genetic treatments outweigh potential fatal risks for patients? This crucial question arises following concerns about Elevidys, a gene therapy for Duchenne muscular dystrophy (DMD). Recent fatalities have stirred conversations around its safety for non-ambulatory patients—these a
In a dynamic landscape marked by regulatory upheavals and evolving financial landscapes, Faisal Zain stands out as a seasoned expert in medical technology and clinical trials. His vast experience in developing cutting-edge medical devices positions him as a luminary in driving innovation. Today, he
